Articles from FDA for the Vaccines and Related Biological Products Advisory Committee Meeting

 

Topic: HPV Vaccines

Dates: November 28-29, 2001    

 

Basic Virology:

 

Howley PM, Lowy DR.  Papillomaviruses and their replication.  Chapter 65 In: Fields Virology.  4th Edition.  Eds: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Lippincott Williams & Wilkins.  2001. 

 

Lowy DR, Howley PM.  Papillomaviruses.  Chapter 66 In: Fields Virology.  4th Edition.  Eds: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE. Lippincott Williams & Wilkins.  2001. 

 

Stubenrauch F, Laimins LA.  Human papillomavirus life cycle: active and latent phases.  Semin Cancer Biol 1999;9:379-86.

 

Natural history of CIN (Cervical Intraepithelial Neoplasia) (with or w/o HPV information):

 

Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.  Lancet 2001;357:1831–36.

 

Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, DeRouen TA, Galloway DA, Vernon D, Kiviat NB.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.  N Engl J Med 1992;327:1272-8.

 

Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP.  Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;92:727-735.

 

Östör AG.  Natural history of cervical intraepithelial neoplasia: a critical review. Int  J Gynecol Pathol 1993;12:186–192.

 

Virology and Cancer or Carcinoma in situ:

 

Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, Adami HO, Gyllensten UB, Melbye M.  Consistent high viral load of human papilloma virus 16 and risk of cervical carcinoma in situ: A nested case-control study.  Lancet 2000;355:2194-8.

 

Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB.  Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study.  Lancet 355:2189, 2000.

 

Ylitalo N, Josefsson A, Melbye M, Sorensen P, Frisch M, Andersen PK, Sparen P, Gustafsson M, Magnusson P, Ponten J, Gyllensten U, Adami HO.  A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.  Cancer Res 2000;60:6027-32.

 

Lehtinen M, Luukkaala T, Wallin KL, Paavonen J, Thoresen S, Dillner J, Hakama M.  Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction.  J Clin Virol 2001;22:117-24.

 

General and Therapy:

 

Bristow RE, Montz FJ.  Workup of the Abnormal Pap Test.  Clinical Cornerstone 3:12-24, 2000.

 

Janicek, MF, Averette HE.  Cervical Cancer: Prevention, Diagnosis, and Therapeutics. CA Cancer J Clin 2001;51:92-114.

 

Wharton JT and Tortolero-Luna G.  Neoplasms of the cervix.  Chapter 112 in: Holland-Frei Cancer Medicine 5th Edition. Editors: R.C. Bast, Jr., D. W. Kufe, R. E. Pollock, R. R. Weichselbaum, J. F. Holland, E. Frei, III May, 2000 B.C. Decker, Inc.